451 related articles for article (PubMed ID: 33562668)
1. Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications.
Cardona-Benavides IJ; de Ramón C; Gutiérrez NC
Cells; 2021 Feb; 10(2):. PubMed ID: 33562668
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli N; Biancon G; Moarii M; Gimondi S; Li Y; de Philippis C; Maura F; Sathiaseelan V; Tai YT; Mudie L; O'Meara S; Raine K; Teague JW; Butler AP; Carniti C; Gerstung M; Bagratuni T; Kastritis E; Dimopoulos M; Corradini P; Anderson KC; Moreau P; Minvielle S; Campbell PJ; Papaemmanuil E; Avet-Loiseau H; Munshi NC
Leukemia; 2018 Dec; 32(12):2604-2616. PubMed ID: 29789651
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the chronology of copy number alterations in Multiple Myeloma.
Aktas Samur A; Minvielle S; Shammas M; Fulciniti M; Magrangeas F; Richardson PG; Moreau P; Attal M; Anderson KC; Parmigiani G; Avet-Loiseau H; Munshi NC; Samur MK
Blood Cancer J; 2019 Mar; 9(4):39. PubMed ID: 30914633
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of multiple myeloma: New insights and modern technologies.
Hultcrantz M; Yellapantula V; Rustad EH
Best Pract Res Clin Haematol; 2020 Mar; 33(1):101153. PubMed ID: 32139018
[TBL] [Abstract][Full Text] [Related]
5. Genomics in multiple myeloma: biology and clinical implications.
Chng WJ; Fonseca R
Pharmacogenomics; 2005 Sep; 6(6):563-73. PubMed ID: 16142997
[TBL] [Abstract][Full Text] [Related]
6. [Classification and genetic abnormalities of multiple myeloma].
Hanamura I; Iida S
Nihon Rinsho; 2015 Jan; 73(1):17-27. PubMed ID: 25626298
[TBL] [Abstract][Full Text] [Related]
7. Genomic complexity of multiple myeloma and its clinical implications.
Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of integrated cytogenetic, somatic variation, and copy number variation analyses in Korean patients with newly diagnosed multiple myeloma.
Lee N; Kim SM; Lee Y; Jeong D; Yun J; Ryu S; Yoon SS; Ahn YO; Hwang SM; Lee DS
PLoS One; 2021; 16(2):e0246322. PubMed ID: 33544757
[TBL] [Abstract][Full Text] [Related]
9. 1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.
Li X; Chen W; Wu Y; Li J; Chen L; Fang B; Feng Y; Liu J; Chen M; Gu J; Huang B; Li J
Oncologist; 2019 Nov; 24(11):e1132-e1140. PubMed ID: 31455749
[TBL] [Abstract][Full Text] [Related]
10. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Walker BA; Boyle EM; Wardell CP; Murison A; Begum DB; Dahir NM; Proszek PZ; Johnson DC; Kaiser MF; Melchor L; Aronson LI; Scales M; Pawlyn C; Mirabella F; Jones JR; Brioli A; Mikulasova A; Cairns DA; Gregory WM; Quartilho A; Drayson MT; Russell N; Cook G; Jackson GH; Leleu X; Davies FE; Morgan GJ
J Clin Oncol; 2015 Nov; 33(33):3911-20. PubMed ID: 26282654
[TBL] [Abstract][Full Text] [Related]
11. A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma.
Bolli N; Li Y; Sathiaseelan V; Raine K; Jones D; Ganly P; Cocito F; Bignell G; Chapman MA; Sperling AS; Anderson KC; Avet-Loiseau H; Minvielle S; Campbell PJ; Munshi NC
Blood Cancer J; 2016 Sep; 6(9):e467. PubMed ID: 27588520
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
[TBL] [Abstract][Full Text] [Related]
13. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
[TBL] [Abstract][Full Text] [Related]
14. Multiple Myeloma Genomics - A Concise Review.
Castaneda O; Baz R
Acta Med Acad; 2019 Apr; 48(1):57-67. PubMed ID: 31264433
[TBL] [Abstract][Full Text] [Related]
15. The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans.
Maura F; Coffey DG; Stein CK; Braggio E; Ziccheddu B; Sharik ME; Du MT; Tafoya Alvarado Y; Shi CX; Zhu YX; Meermeier EW; Morgan GJ; Landgren O; Bergsagel PL; Chesi M
Nat Commun; 2024 May; 15(1):3844. PubMed ID: 38714690
[TBL] [Abstract][Full Text] [Related]
16. A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5.
White BS; Lanc I; O'Neal J; Gupta H; Fulton RS; Schmidt H; Fronick C; Belter EA; Fiala M; King J; Ahmann GJ; DeRome M; Mardis ER; Vij R; DiPersio JF; Levy J; Auclair D; Tomasson MH
Blood Cancer J; 2018 Mar; 8(3):35. PubMed ID: 29563506
[TBL] [Abstract][Full Text] [Related]
17. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
[TBL] [Abstract][Full Text] [Related]
18. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.
Schilling G; Dierlamm J; Hossfeld DK
Hematol Oncol; 2005; 23(3-4):102-7. PubMed ID: 16342296
[TBL] [Abstract][Full Text] [Related]
20. DMG26: A Targeted Sequencing Panel for Mutation Profiling to Address Gaps in the Prognostication of Multiple Myeloma.
Cutler SD; Knopf P; Campbell CJV; Thoni A; Abou El Hassan M; Forward N; White D; Wagner J; Goudie M; Boudreau JE; Kennedy BE; Gujar S; Gaston D; Elnenaei MO
J Mol Diagn; 2021 Dec; 23(12):1699-1714. PubMed ID: 34562616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]